What’s the problem? Well, the ExaStim and other Transcutaneous Spinal Stimulation (TSS) devices LOOK very similar to another electrical stimulation device: The TENS (or Transcutaneous Electrical Nerve Stimulation). And there is already a billing code for TENS, (which carries a reimbursement of only $517). Right now, CMS’ preliminary decision is to drop TSS into the TENS code.

It all started when I filled out a generic webpage portal titled, “request for meeting.” No special relationships, no “inside track.” Just a concerned citizen (me) reaching out to their United States Senator. Montana Senator Tim Sheehy’s office responded right away and a virtual meeting was initiated with the Senator’s State Director and National Security Advisor. They met with myself and two local SCI friends...

The FDA is currently open to public comments from the SCI community until October 30th. If you are a stakeholder in this field (PLEX, Family/Caregiver, Researcher, Clinician, Industry, Foundation, etc) please share your experience of SCI by submitting a public comment to the FDA now. And if you’re looking for a pointed message, consider highlighting the uniqueness of SCI - that it is not a simple injury, but is instead a condition of conditions (i.e. it involves a cascade of secondary complications like UTIs, nerve pain, autonomic dysreflexia, etc) that severely effect our...